Michael Kates

Dr. Michael Kates joined DavosPharma in 2011. He is responsible for the business development and management of Davos’ fully Integrated Drug Discovery Service Platform. Prior to this, he worked as a medicinal chemist at both Wyeth Laboratories and DuPont-Merck. He holds a B.S. degree in chemistry, a Ph.D. from Villanova University, and Post Doctoral Research Fellow at Brown University. Dr. Kates is an Adjunct Associate Professor of Medicinal Chemistry at the University of New England, School of Pharmacy, and has 21 publications and contributed talks.